← FDA Drug Approvals (Drugs@FDA)

MACITENTAN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2024-01-09

Drug application

FDA Application #
ANDA211195
Application type
Abbreviated New Drug Application (Generic)
Brand name
MACITENTAN
Generic name
Macitentan
Active ingredients
MACITENTAN
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
APOTEX
First approval
2024-01-09

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown